Caladrius Bio (CLBS)

$1.10 0.02 (1.79%)
13:54 EDT CLBS Stock Quote Delayed 30 Minutes

CLBS Stock: Why Caladrius Biosciences Is Soaring Today

Caladrius Biosciences is focused on treating coronary microvascular dysfunction. The condition is most common among women, especially after menopause.
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 65.47M
PE Ratio -1.20
EPS -0.92
Volume (Avg. Vol.) 232,769
Day's Range 1.10 - 1.12
52-Week Range 1.11 - 4.89
Dividend & Yield N/A (N/A)